146 related articles for article (PubMed ID: 37722463)
21. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.
Mirouse A; Parrot A; Audigier V; Demoule A; Mayaux J; Géri G; Mariotte E; Bréchot N; de Prost N; Vautier M; Neuville M; Bigé N; de Montmollin E; Cacoub P; Resche-Rigon M; Cadranel J; Saadoun D
Crit Care; 2020 May; 24(1):231. PubMed ID: 32423434
[TBL] [Abstract][Full Text] [Related]
22. Infection in systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a potential key to improve outcomes.
Li M; Bai W; Wang Y; Song L; Zhang S; Zhao J; Wu C; Li M; Tian X; Zeng X
Clin Rheumatol; 2023 Jun; 42(6):1573-1584. PubMed ID: 36797549
[TBL] [Abstract][Full Text] [Related]
23. Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study.
Pardos-Gea J; Marques-Soares JR; Buján S; Ordi-Ros J; Alijotas-Reig J
Rheumatology (Oxford); 2022 Mar; 61(3):1053-1061. PubMed ID: 34115832
[TBL] [Abstract][Full Text] [Related]
24. Diffuse Alveolar Hemorrhage as a Manifestation of Childhood-Onset Systemic Lupus Erythematosus.
Singla S; Canter DL; Vece TJ; Muscal E; DeGuzman M
Hosp Pediatr; 2016 Aug; 6(8):496-500. PubMed ID: 27390368
[TBL] [Abstract][Full Text] [Related]
25. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea.
Kwok SK; Moon SJ; Ju JH; Park KS; Kim WU; Cho CS; Kim HY; Park SH
Lupus; 2011 Jan; 20(1):102-7. PubMed ID: 20956464
[TBL] [Abstract][Full Text] [Related]
26. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
[TBL] [Abstract][Full Text] [Related]
27. The challenges in diagnosing pediatric primary antiphospholipid syndrome.
Demir S; Keskin A; Sağ E; Kaya Akca Ü; Atalay E; Cüceoğlu MK; Batu Akal ED; Özen S; Bilginer Y
Lupus; 2022 Sep; 31(10):1269-1275. PubMed ID: 35746827
[TBL] [Abstract][Full Text] [Related]
28. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
[TBL] [Abstract][Full Text] [Related]
29. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
Front Immunol; 2018; 9():2644. PubMed ID: 30524428
[No Abstract] [Full Text] [Related]
30. Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
Yachoui R; Sehgal R; Amlani B; Goldberg JW
Semin Arthritis Rheum; 2015 Jun; 44(6):652-7. PubMed ID: 25481816
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.
Dupré A; Morel N; Yelnik C; Moguelet P; Le Guern V; Stammler R; Nguyen Y; Paule R; Dufrost V; Ackermann F; Benhamou Y; Godeau B; Lambert M; Duffau P; Mekinian A; Saadoun D; Mouthon L; Hachulla E; Maillard H; Levesque H; Morell-Dubois S; Leroux G; Piette JC; Chasset F; Costedoat-Chalumeau N
JAMA Dermatol; 2023 Jan; 159(1):62-67. PubMed ID: 36477813
[TBL] [Abstract][Full Text] [Related]
32. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
Stammler R; Nguyen Y; Yelnik C; Le Guern V; Lambert M; Paule R; Hachulla E; Mouthon L; Dupré A; Ackermann F; Dufrost V; Wahl D; Godeau B; Leroux G; Benhamou Y; Lazaro E; Daugas E; Bezanahary H; Mekinian A; Piette JC; Morel N; Costedoat-Chalumeau N
J Thromb Haemost; 2023 May; 21(5):1258-1265. PubMed ID: 36792010
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics and Risk Factors of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: a Systematic Review and Meta-Analysis Based on Observational Studies.
Xu T; Zhang G; Lin H; Xie Y; Feng Y; Zhang X; Dong G
Clin Rev Allergy Immunol; 2020 Dec; 59(3):295-303. PubMed ID: 31440948
[TBL] [Abstract][Full Text] [Related]
35. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes.
García-Grimshaw M; Posadas-Pinto DR; Jiménez-Ruiz A; Valdés-Ferrer SI; Cadena-Fernández A; Torres-Ruiz JJ; Barrientos-Guerra JD; Amancha-Gabela M; Chiquete E; Flores-Silva FD; Cantú-Brito C
Lupus; 2022 Feb; 31(2):228-237. PubMed ID: 35042376
[TBL] [Abstract][Full Text] [Related]
37. [A clinical analysis of 32 patients with diffuse alveolar hemorrhage in diffuse connective tissue diseases].
Chen GX; Dong Y; Ju ZB
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):362-5. PubMed ID: 18953941
[TBL] [Abstract][Full Text] [Related]
38. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
[TBL] [Abstract][Full Text] [Related]
39. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
40. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
